EMILY FERNANDEZ: Open Payments
NPI 1740502277 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$381 in 9 payments from 7 companies in 2025. Trend: 2023 $292 · 2024 $155 · 2025 $381
Food & beverage: $281Education: $100
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $118 |
| SEAGEN INC. | 1 | $100 |
| AstraZeneca Pharmaceuticals LP | 2 | $56 |
| Astellas Pharma US Inc | 2 | $43 |
| Tactile Systems Technology Inc | 1 | $24 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $20 |
Products named: JEMPERLI, LYNPARZA, Veozah, Flexitouch Plus, AKYNZEO, Enhertu.
Industry payments across NV — which companies pay providers there.
